Attached files
| file | filename |
|---|---|
| 8-K/A - FORM 8-K/A - Kedem Pharmaceuticals Inc. | ghv-8ka.htm |
|
n South Surrey
1688 – 152nd Street
Suite 306
South Surre
Canada V4A 4N2
Phone 604 538 1611
Fax 604 538 1633
|
October 19, 2011
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
U.S.A.
Dear Ladies and Gentlemen:
Re: Kedem Pharmaceuticals Inc. (the “Company”)
This letter confirms that we have reviewed Item 4.01, Changes in Registrant’s Certifying Accountant, of the Company’s Form 8-K/A dated October 19, 2011 and are in agreement with the statements made therein as it pertains to our firm.
Yours very truly,
/s/ UHY LDMB ADVISORS INC.
UHY LDMB ADVISORS INC.
UHY LDMB ADVISORS INC.
CHARTERED ACCOUNTANTS